China · Delayed Price · Currency is CNY Cisen Pharmaceutical Statistics
Total Valuation
SHA:603367 has a market cap or net worth of CNY 5.78 billion. The enterprise value is 2.17 billion.
| Market Cap | 5.78B |
| Enterprise Value | 2.17B |
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Sep 16, 2026 |
Share Statistics
SHA:603367 has 452.75 million shares outstanding. The number of shares has decreased by -1.20% in one year.
| Current Share Class | 452.75M |
| Shares Outstanding | 452.75M |
| Shares Change (YoY) | -1.20% |
| Shares Change (QoQ) | -3.82% |
| Owned by Insiders (%) | 6.45% |
| Owned by Institutions (%) | 3.97% |
| Float | 205.86M |
Valuation Ratios
The trailing PE ratio is 14.87.
| PE Ratio | 14.87 |
| Forward PE | n/a |
| PS Ratio | 1.73 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | 13.49 |
| P/OCF Ratio | 13.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.09, with an EV/FCF ratio of 5.06.
| EV / Earnings | 5.60 |
| EV / Sales | 0.65 |
| EV / EBITDA | 5.09 |
| EV / EBIT | 8.77 |
| EV / FCF | 5.06 |
Financial Position
The company has a current ratio of 4.73, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.73 |
| Quick Ratio | 3.88 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.06 |
| Interest Coverage | 227.02 |
Financial Efficiency
Return on equity (ROE) is 6.21% and return on invested capital (ROIC) is 8.28%.
| Return on Equity (ROE) | 6.21% |
| Return on Assets (ROA) | 2.01% |
| Return on Invested Capital (ROIC) | 8.28% |
| Return on Capital Employed (ROCE) | 3.79% |
| Weighted Average Cost of Capital (WACC) | 5.46% |
| Revenue Per Employee | 1.07M |
| Profits Per Employee | 124,302 |
| Employee Count | 3,114 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.49 |
Taxes
In the past 12 months, SHA:603367 has paid 59.99 million in taxes.
| Income Tax | 59.99M |
| Effective Tax Rate | 13.30% |
Stock Price Statistics
The stock price has decreased by -40.05% in the last 52 weeks. The beta is 0.22, so SHA:603367's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -40.05% |
| 50-Day Moving Average | 13.91 |
| 200-Day Moving Average | 15.05 |
| Relative Strength Index (RSI) | 34.08 |
| Average Volume (20 Days) | 4,622,207 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603367 had revenue of CNY 3.34 billion and earned 387.08 million in profits. Earnings per share was 0.86.
| Revenue | 3.34B |
| Gross Profit | 1.67B |
| Operating Income | 247.21M |
| Pretax Income | 451.13M |
| Net Income | 387.08M |
| EBITDA | 423.46M |
| EBIT | 247.21M |
| Earnings Per Share (EPS) | 0.86 |
Balance Sheet
The company has 3.68 billion in cash and 26.71 million in debt, with a net cash position of 3.66 billion or 8.08 per share.
| Cash & Cash Equivalents | 3.68B |
| Total Debt | 26.71M |
| Net Cash | 3.66B |
| Net Cash Per Share | 8.08 |
| Equity (Book Value) | 6.41B |
| Book Value Per Share | 14.06 |
| Working Capital | 4.53B |
Cash Flow
In the last 12 months, operating cash flow was 437.31 million and capital expenditures -8.59 million, giving a free cash flow of 428.72 million.
| Operating Cash Flow | 437.31M |
| Capital Expenditures | -8.59M |
| Depreciation & Amortization | 176.25M |
| Net Borrowing | 1.11M |
| Free Cash Flow | 428.72M |
| FCF Per Share | 0.95 |
Margins
Gross margin is 50.18%, with operating and profit margins of 7.41% and 11.60%.
| Gross Margin | 50.18% |
| Operating Margin | 7.41% |
| Pretax Margin | 13.52% |
| Profit Margin | 11.60% |
| EBITDA Margin | 12.69% |
| EBIT Margin | 7.41% |
| FCF Margin | 12.85% |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 2.51%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 2.51% |
| Dividend Growth (YoY) | -7.84% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 66.02% |
| FCF Payout Ratio | 39.71% |
| Buyback Yield | 1.20% |
| Shareholder Yield | 3.71% |
| Earnings Yield | 6.73% |
| FCF Yield | 7.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603367 has an Altman Z-Score of 5.33 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.33 |
| Piotroski F-Score | 6 |